Trajan joins BioMelbourne Network

Trajan joins BioMelbourne Network

January 31, 2014

Trajan Scientific and Medical (Trajan) is now a member of BioMelbourne Network. As a group of companies with headquarters in Melbourne, Trajan is looking forward to strengthening connections with local scientific organisations, business leaders and government.

Stephen Tomisich, Trajan’s Chief Executive Officer said, “We hope our membership helps us to engage with other members to support and contribute to the success of the Australian scientific industry, in particular biotechnology in Victoria.

“We are proud to be an Australian owned and operated global company, building on humble beginnings in Ringwood with SGE Analytical Science over 50 years ago, growing to develop new analytical technologies for the scientific community and society.”

Trajan’s focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements, especially those that can lead to portability, miniaturization and affordability.

“We seek opportunities for each of our companies with their unique capabilities. Trajan is able to facilitate collaboration with one or more of our companies in Australia and around the world.” said Robert Lyon, Head of Corporate Development at Trajan.

Trajan encompasses a group of companies including SGE Analytical Science, Grale HDS and SciMed Precision with over 300 staff worldwide, and customers in over 100 countries.

SGE Analytical Science is a world leader in creating components and consumables used in scientific analysis. SGE has substantial capability in materials science, chemistry, fabrication and distribution.

SciMed Precision offers complete solutions in design and production engineering of high precision complex components for analytical and life science applications.

Grale HDS is a pathology supply partner like no other. Supplying quality products for more than 30 years, they assist laboratory managers tackle operational challenges.

“Through true customer focus and partnerships, we aim to make a positive impact on the world of analytical and medical science.” said Mr Tomisich. 

More Information
BioMelbourne Network www.biomelbourne.org




Also in News

Global analytical science and device company Trajan Group announces IPO and $90M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $90M capital injection to fuel next phase of growth

May 17, 2021

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More

Close-up of the LLE mixer tool on the Trajan Automation autosampler
Trajan’s “Lab-in-a-Syringe” product development program promises greater laboratory efficiencies

March 30, 2021

Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.

Read More